Mometasone furoate nasal spray in Italian children with seasonal allergic rhinitis: a comprehensive assessment
CONCLUSIONS: The present study documented that a 3-week MFNS treatment was able to significantly dampen type 2 inflammation, improve QoL, and reduce severity of symptoms in Italian children with SAR, and was safe.PMID:36086965 | DOI:10.15586/aei.v50i5.643
Source: Allergologia et Immunopathologia - Category: Allergy & Immunology Authors: Cristiana Indolfi Giulio Dinardo Giuseppina Rosaria Umano Angela Klain Marcella Contieri Alberto Decimo Fabio Decimo Giorgio Ciprandi Michele Miraglia Del Giudice Source Type: research
More News: Allergy & Immunology | Children | Corticosteroid Therapy | Cytology | Hay Fever | Italy Health | Mometasone | Nasonex | Pediatrics | Study